These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Active antiviral T-lymphocyte response can be redirected against tumor cells by antitumor antibody x MHC/viral peptide conjugates. Cesson V, Stirnemann K, Robert B, Luescher I, Filleron T, Corradin G, Mach JP, Donda A. Clin Cancer Res; 2006 Dec 15; 12(24):7422-30. PubMed ID: 17189415 [Abstract] [Full Text] [Related]
3. Monoclonal anti-idiotype antibody 6G6.C4 fused to GM-CSF is capable of breaking tolerance to carcinoembryonic antigen (CEA) in CEA-transgenic mice. Schwegler C, Dorn-Beineke A, Nittka S, Stocking C, Neumaier M. Cancer Res; 2005 Mar 01; 65(5):1925-33. PubMed ID: 15753392 [Abstract] [Full Text] [Related]
12. Construction, production, and characterization of humanized anti-Lewis Y monoclonal antibody 3S193 for targeted immunotherapy of solid tumors. Scott AM, Geleick D, Rubira M, Clarke K, Nice EC, Smyth FE, Stockert E, Richards EC, Carr FJ, Harris WJ, Armour KL, Rood J, Kypridis A, Kronina V, Murphy R, Lee FT, Liu Z, Kitamura K, Ritter G, Laughton K, Hoffman E, Burgess AW, Old LJ. Cancer Res; 2000 Jun 15; 60(12):3254-61. PubMed ID: 10866319 [Abstract] [Full Text] [Related]
13. Reduction of human melanoma tumor growth in severe combined immunodeficient mice by passive transfer of antibodies induced by a high molecular weight melanoma-associated antigen mimotope vaccine. Wagner S, Krepler C, Allwardt D, Latzka J, Strommer S, Scheiner O, Pehamberger H, Wiedermann U, Hafner C, Breiteneder H. Clin Cancer Res; 2008 Dec 15; 14(24):8178-83. PubMed ID: 19088033 [Abstract] [Full Text] [Related]
14. A monoclonal antibody against neem leaf glycoprotein recognizes carcinoembryonic antigen (CEA) and restricts CEA expressing tumor growth. Das A, Barik S, Banerjee S, Bose A, Sarkar K, Biswas J, Baral R, Pal S. J Immunother; 2014 Oct 15; 37(8):394-406. PubMed ID: 25198527 [Abstract] [Full Text] [Related]
15. Mimotope vaccination for epitope-specific induction of anti-CD20 antibodies. Li M, Yan Z, Han W, Zhang Y. Cell Immunol; 2006 Feb 15; 239(2):136-43. PubMed ID: 16814270 [Abstract] [Full Text] [Related]
18. CD20 mimicry by a mAb rituximab-specific linear peptide: a potential tool for active immunotherapy of autoimmune diseases. Perosa F, Favoino E, Caragnano MA, Dammacco F. Ann N Y Acad Sci; 2005 Jun 15; 1051():672-83. PubMed ID: 16127008 [Abstract] [Full Text] [Related]
19. Human monocytes expressing a CEA-specific chimeric CD64 receptor specifically target CEA-expressing tumour cells in vitro and in vivo. Biglari A, Southgate TD, Fairbairn LJ, Gilham DE. Gene Ther; 2006 Apr 15; 13(7):602-10. PubMed ID: 16397508 [Abstract] [Full Text] [Related]
20. A mimotope peptide-based anti-cancer vaccine selected by BAT monoclonal antibody. Hardy B, Raiter A. Vaccine; 2005 Jul 29; 23(34):4283-91. PubMed ID: 15919139 [Abstract] [Full Text] [Related] Page: [Next] [New Search]